Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha-1-Antitrypsin deficiency.

D Alagille

    Hepatology (Baltimore, Md.)
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Alpha-1-antitrypsin deficiency (AATD) causes liver disease in Pi ZZ homozygous children. Many infants with AATD and prolonged neonatal cholestasis develop cirrhosis, with poor prognostic indicators identified.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    History of pediatric liver transplantation in Europe.

    Acta gastro-enterologica Belgica·2004
    Same author

    Synthesis and in vitro cytotoxic evaluation of N-substituted benzo[5,6]cycloheptal[b]indoles.

    Chemical & pharmaceutical bulletin·2001
    Same author

    Alagille syndrome today.

    Clinical and investigative medicine. Medecine clinique et experimentale·1996
    Same author

    Deleted chromosome 20 from a patient with Alagille syndrome isolated in a cell hybrid through leucine transport selection: study of three candidate genes.

    Mammalian genome : official journal of the International Mammalian Genome Society·1994
    Same author

    [Renal involvement in the Alagille syndrome].

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·1994
    Same author

    [Jean-François Borel: discoverer of cyclosporin].

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·1994
    Same journal

    Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

    Hepatology (Baltimore, Md.)·2026
    Same journal

    A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.

    Hepatology (Baltimore, Md.)·2026
    Same journal

    AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Candidate evaluation.

    Hepatology (Baltimore, Md.)·2026
    Same journal

    H4K12 lactylation drives TREM2high macrophages differentiation in liver fibrosis.

    Hepatology (Baltimore, Md.)·2026
    Same journal

    Good vibrations: Using VCTE to predict hepatic decompensation in MASLD.

    Hepatology (Baltimore, Md.)·2026
    Same journal

    One size does not fit all: Global variability in noninvasive testing for MASLD.

    Hepatology (Baltimore, Md.)·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Pediatric Gastroenterology
    • Genetic Liver Diseases

    Background:

    • Alpha-1-antitrypsin deficiency (AATD) is a genetic disorder that can lead to liver disease, primarily in individuals with the Pi ZZ genotype.
    • Liver disease in AATD predominantly affects Pi ZZ homozygous children, presenting with varying severity.
    • Neonatal cholestasis is a recognized early manifestation of AATD-related liver disease in infants.

    Purpose of the Study:

    • To investigate the clinical course and prognostic factors of liver disease in infants with alpha-1-antitrypsin deficiency (AATD) and prolonged neonatal cholestasis.
    • To identify specific clinical and histological features associated with poor outcomes, including cirrhosis and mortality.
    • To evaluate the effectiveness of current treatment strategies in managing AATD-related cirrhosis in children.

    Related Experiment Videos

    Main Methods:

    • Retrospective analysis of 45 Pi ZZ infants diagnosed with prolonged neonatal cholestasis.
    • Clinical assessment including jaundice duration, splenomegaly, hepatomegaly, and liver function tests.
    • Histological examination for liver fibrosis and bile duct paucity.
    • Evaluation of outcomes such as cirrhosis development, portal hypertension, and mortality.

    Main Results:

    • Twenty-five out of 45 (55.6%) Pi ZZ infants with prolonged neonatal cholestasis developed cirrhosis.
    • Poor prognostic indicators included persistent jaundice beyond 6 months, early splenomegaly, hard hepatomegaly, abnormal liver function, and early portal fibrosis.
    • The most severe disease course was observed in infants with histological paucity of interlobular bile ducts.
    • Portal hypertension was present in 19 of 25 children with cirrhosis, and 8 died during childhood.

    Conclusions:

    • Prolonged neonatal cholestasis in Pi ZZ infants is a significant risk factor for developing cirrhosis.
    • Specific clinical and histological findings are crucial for predicting poor prognosis in AATD-related liver disease.
    • While dietary and surgical interventions showed limited benefit, the long-term prognosis for Pi ZZ children with cirrhosis remains unpredictable.